Form D · Private Equity Fund
Cimarron Healthcare Capital Fund II, LP
Salt Lake City, UT · CIK 0001840208
Offering snapshot reported Feb 6, 2023 · SEC filing
- Reported sold
- $119M Indefinite offering
- Investors reported
- 114 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 18, 2021 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$104,380,000 → $118,670,000
- Reported investors86 → 114
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 6, 2023 | Amendment | $118,670,000 | $14,290,000vs Jan 19, 2022 | 114 | SEC filing |
| Jan 19, 2022 | Initial | $104,380,000 | No comparison | 86 | SEC filing |
| Jan 25, 2021 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $3.5M (estimated)
- Finders' fees
- $0
- Form D file number
- Not reported
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Houlihan Lokey Capital, Inc. | 17708 |
Source: Form D, filed Feb 6, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Nadauld | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:Salt Lake City, UT, 84121